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BACKGROUND. Public awareness and education may lead to the detection of thin-
ner melanomas, which may result in a decrease in morbidity and mortality rates.
Which detection patterns, lesion, and patient characteristics are associated with
early detection?
METHODS. Using the University of Michigan prospective melanoma database, the
detection patterns, lesion characteristics, and patient characteristics of 1515 con-
secutive patients with in situ or invasive cutaneous melanomas were reviewed.
Tumor thickness (measured in millimeters) was evaluated in relationship to de-
tection patterns (patient, physician, spouse), lesion characteristics (change in
color, size, shape/elevation, ulceration, bleeding, tenderness, itching), and patient
characteristics (gender, skin type, number of atypical and clinically benign nevi,
history of sunburn, personal and family history of melanoma).
RESULTS. Patient characteristics associated with early detection included female
gender, at least one atypical nevus, greater than 20 clinically benign nevi, and/or
a personal history of melanoma. Skin types I, II, and III, a history of sunburn,
and/or a family history of melanoma were also associated with thinner lesions, but
these associations were not statistically significant. Lesion characteristics associ-
ated with earlier detection included a change in color, size, shape/elevation,
and/or itching. Physician-detected melanomas were significantly thinner than
patient or spouse-detected lesions.
CONCLUSIONS. Educational campaigns should include increasing melanoma
awareness in males and educating the public on the early signs and symptoms.
Education should be directed at both high and low-risk groups. Physicians should
consider performing total skin examinations routinely on patients. Although they
detect a relatively small percentage of all melanomas, physicians detect signifi-
cantly thinner lesions. Cancer 2002;95:1562– 8. © 2002 American Cancer Society.
DOI 10.1002/cncr.10880
KEYWORDS: melanoma, demographics, detection, signs, symptoms, personal his-
tory, family history.
Melanoma is the deadliest form of skin carcinoma. The annualpercent increase in the incidence of melanoma exceeds that of
any other cancer.1 The estimated lifetime risk in the United States for
an invasive melanoma is 1 in 75 born in the year 2000.2 In 2000,
approximately 47,700 invasive melanomas and 28,600 in situ mela-
nomas were diagnosed and approximately 7700 patients died of the
disease.3
Public awareness and education about melanoma may lead to a
true decrease in the incidence of melanoma and have a more imme-
diate impact on the detection of thinner melanomas, ultimately re-
sulting in a decrease in the mortality rate. But who is detecting thin
melanomas and where should attention be focused to increase the
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likelihood that a melanoma will be detected earlier?
This is the largest prospective study to analyze the
relationship between tumor thickness (Breslow depth)
and patient demographics, detection patterns, lesion
signs and symptoms, and a personal and family his-
tory of melanoma. The importance of early detection
cannot be overemphasized. The information gained
from this study may provide insight on whom to focus
educational and screening campaigns by identifying
individuals who are more likely to present with deeper
lesions.
MATERIALS AND METHODS
Study approval was granted by the University of Mich-
igan Institutional Review Board for Human Subject
Research. Our prospective melanoma database was
searched to identify all patients with primary cutane-
ous invasive and in situ melanomas who were evalu-
ated between January 1, 1998 and December 31, 1999.
All histologic slides were reviewed by a University of
Michigan melanoma dermatopathologist to confirm
the diagnosis of primary cutaneous melanoma. Tumor
thickness measured in millimeters (mm) was recorded
as the Breslow depth of invasion. Specific clinical data
were recorded accurately by a melanoma attending
physician and systematically entered prospectively
into the melanoma database. Unknown primary and
noncutaneous melanomas were excluded. Using these
criteria, the study population consisted of 1515 con-
secutive patients with 1630 lesions.
Patient demographics, detection patterns, lesion
characteristics, and personal and family history of
melanoma were extracted from the database. 1) Pa-
tient demographics included gender, age at diagnosis
of first primary melanoma, skin type, number of atyp-
ical and clinically benign nevi, and history of sunburn.
Skin type categories were defined as follows: I (always
burn, never tan), II (always burn, sometimes tan), III
(sometimes burn, always tan), IV (never burn, always
tan), V (very dark, black skin), and unknown. The
number of atypical and clinically benign nevi (based
on total body skin examination by a melanoma at-
tending physician and/or histologic diagnosis) was
categorized as none, 1–5, 6 –20, greater than 20, or
unknown. History of sunburn response categories
were yes, no, and unknown. The question was used
only to examine tumor thickness in relationship to
perceived exposure, not actual or quantitative expo-
sure. 2) Detection patterns determined who first de-
tected the primary melanoma based on patient his-
tory. Categories included patient, spouse, physician,
friend, sibling, son/daughter, parent, nurse, other, and
unknown. 3) Regarding the lesion characteristics of
the primary melanoma, patients were questioned
about change in color, size, shape/elevation, ulcer-
ation, bleeding, tenderness, and itching. Response
categories were yes, no, and unknown. 4) Regarding
personal history of melanoma, detection pattern and
lesion characteristics were available on each primary
melanoma among study patients with multiple prima-
ries. Family history was defined as at least one blood
relative diagnosed with melanoma and response cat-
egories were yes, no, and unknown.
Statistical Analysis
Comparisons of continuous variables such as Breslow
depth and age were made with Student two-sample t
tests, assuming unequal variance. All P values are two
tailed. Tests for association of the proportional distri-
bution of categorical variables were made with Pear-
son’s chi-square tests. Descriptive statistics are pre-
sented as means  95% confidence intervals. The data
were analyzed with Microsoft Excel 2000 Software (Mi-
crosoft, Bellevue, WA) and SAS Statistical Software
(SAS Institute, Cary, NC).
RESULTS
Patient Demographics
The mean Breslow depth of all primaries was 1.02 mm
(Tables 1, 2). The majority of lesions were less than 1
mm thick (25% in situ and 43%  1 mm), whereas only
4% were greater than or equal to 4 mm (1–1.99 mm
[18%], 2–3.99 mm [10%]). The study population con-
sisted of about the same number of males and fe-
males. The mean Breslow depth of all primaries in
females (0.89 mm) was less than the mean depth in
males (1.14 mm; P  0.005). The mean age at diagno-
sis of the first primary melanoma was 52.6 years. The
majority of patients (72%) were between the ages of 21
and 65, 26% of the patients were older than 65 years of
age, and only 2% of patients were younger than 21
years of age. Females (48.9 years) were younger than
males (56.1 years) at diagnosis of their first primaries
(P  0.001).
Most patients had skin types I, II, or III. The mean
Breslow depth of lesions in patients with skin types I,
TABLE 1
Patient Demographicsa
All (%) Males (%) Females (%)
No. of patients 1515 (100) 774 (51) 741 (49)
No. of lesions 1630 (100) 849 (52) 781 (48)
Mean depth (mm) 1.02  0.08 1.14  0.11 0.89  0.11
Mean age (yrs; first primary) 52.6  0.8 56.1  1.1 48.9  1.2
a  95% confidence interval.
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II, or III (1.00 mm) was less than that in patients with
skin types IV or V (1.58 mm), but this was not statis-
tically significant (P  0.1).
One half of the patients examined had at least one
atypical nevus with similar percentages of males and
females. The mean Breslow depth in both males and
females with at least one atypical nevus (0.95 mm and
0.79 mm, respectively) was less than that in males and
females without atypical nevi (1.34 mm and 1.01 mm,
respectively; P  0.001 and P  0.05). Stratifying all
patients with atypical nevi based on number 1–5,
6 –20, and greater than 20 revealed a decreasing trend
in mean Breslow depths (0.89 mm, 0.86 mm, 0.77 mm,
respectively), but there were no statistically significant
differences between the groups. However, females
with greater than 20 atypical nevi had significantly
thinner lesions (0.36 mm) than females with no atyp-
ical nevi (1.01 mm; P  0.001), 1–5 (0.84 mm; P
 0.001), and 6 –20 (0.68 mm; P  0.05) atypical nevi.
The majority of patients had at least one clinically
benign nevus. Only patients with greater than 20 clin-
ically benign nevi had significantly thinner lesions
(0.79 mm) than patients with 1–5 (1.16 mm; P  0.001)
and 6 –20 (1.06 mm; P  0.001) clinically benign nevi.
The majority of patients reported having at least
one blistering or peeling sunburn with equal percent-
ages of males and females. The mean Breslow depth of
lesions in patients reporting a history of sunburn (0.97
mm) was less than the mean depth in patients who
recalled no history of sunburn (1.17 mm), but this was
not statistically significant (P  0.07).
Detection Patterns
The majority of lesions were detected by either the
patient, physician, or spouse (Table 3). Physician-de-
tected lesions were thinner (0.40 mm) than either
self-detected (1.17 mm; P  0.001) or spouse-detected
(1.00 mm; P  0.001) lesions.
In both genders, the majority of melanoma were
self-detected. In males, the mean Breslow depth of
self-detected lesions (1.42 mm) was greater than that
of the lesions detected by either the spouse (1.04 mm;
P  0.005) or physician (0.42 mm; P  0.001). In
females, the mean Breslow depth of self-detected le-
sions (0.98 mm) was greater than physician-detected
lesions (0.35 mm; P0.001) but was not significantly
different from spouse-detected lesions (0.72 mm; P
 0.2).
Females (76%) were more likely to self-detect their
lesions than males (52%; P  0.001). Females self-
detected thinner melanomas (0.98 mm) than males
(1.42 mm; P  0.001). Males (19%) were more likely
than females (3%) to have a lesion detected by their
spouse (P  0.001). Males (19%) were also more likely
than females (9%) to have a lesion detected by their
physician (P  0.001).
TABLE 2
Patient Demographicsa
All (n  1515) Males (n  774) Females (n  741)
No. (%) Mean depth (mm) No. (%) Mean depth (mm) No. (%) Mean depth (mm)
Skin type
I, II, III 1451 (96) 1.00  0.08
IV, V 39 (3) 1.58  0.71
Atypical nevi
None 743 (49) 1.18  0.13 384 (50) 1.34  0.19 359 (48) 1.01  0.18
 1 763 (50) 0.87  0.09 386 (50) 0.95  0.13 377 (51) 0.79  0.13
1–5 564 (37) 0.89  0.11 270 (35) 0.94  0.15 294 (40) 0.84  0.15
6–20 153 (10) 0.86  0.18 82 (11) 1.02  0.27 71 (10) 0.68  0.22
 20 46 (3) 0.77  0.38 34 (4) 0.90  0.50 12 (2) 0.36  0.23
Clinically benign nevi
None 59 (4) 1.33  0.55 36 (5) 1.43  0.63 23 (3) 1.17  1.09
 1 1444 (95) 1.01  0.08 731 (94) 1.13  0.11 713 (96) 0.88  0.11
1–5 378 (25) 1.16  0.18 205 (26) 1.35  0.25 173 (23) 0.93  0.26
6–20 649 (43) 1.06  0.12 328 (42) 1.11  0.17 321 (43) 1.01  0.17
 20 417 (28) 0.79  0.11 198 (26) 0.94  0.19 219 (30) 0.65  0.10
Sunburn history
Yes 1230 (81) 0.97  0.09 627 (81) 1.08  0.12 603 (81) 0.87  0.12
No 250 (17) 1.17  0.19 128 (17) 1.34  0.30 122 (16) 0.96  0.23
a Categories may not total 100% due to missing or unknown responses. Percentages of subgroups 1–5, 6 –20, and  20 may not add to percentage of group  1 due to rounding errors.  95% confidence interval.
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Lesion Signs and Symptoms
The most common changes noted by patients were
the color, size, and/or shape/elevation of a lesion (Ta-
ble 4). Less common changes included ulceration,
bleeding, tenderness, and itching. Mean Breslow
depths associated with a change in color (1.15 mm),
size (1.33 mm), shape/elevation (1.47 mm), and itch-
ing (1.70 mm) were less than mean Breslow depths
associated with ulceration (2.69 mm), bleeding (2.63
mm), and tenderness (2.44 mm; all P  0.005).
Personal and Family History of Melanoma
Of the 1630 cutaneous in situ and invasive melano-
mas, 1530 (94%) were first primaries (15 lesions were
concurrently diagnosed first primaries), 79 (5%) were
second primaries, 18 (1%) were third primaries, and 3
were fourth or fifth primaries (Table 5). In both males
and females, second (0.46 mm and 0.34 mm, respec-
tively; P  0.001 and P  0.001) and third (0.31 mm
and 0.24 mm, respectively; P  0.001 and P  0.005)
primary melanomas were detected earlier than first
primary melanomas (1.20 mm and 0.91 mm, respec-
tively). Although the mean Breslow depth of first pri-
maries in females was less than that in males (P
 0.001), the mean Breslow depths of second and
third primaries were not significantly different be-
tween genders.
Fifteen percent of patients reported a blood rela-
tive with melanoma. The mean Breslow depth in pa-
tients with a family history of melanoma (0.83 mm)
was less than that in patients without a family history
of melanoma, but this was not statistically significant
(1.02 mm; P  0.08). The difference in Breslow depths
between males with (0.82 mm) and without (1.14 mm)
a family history of melanoma was statistically signifi-
cant (P  0.01).
DISCUSSION
Melanoma is a potentially curable cancer. Although
the incidence and mortality rates have continued to
increase, survival has also increased because of early
diagnosis.4 Early detection of melanoma impacts mor-
bidity and mortality rates and has substantial eco-
nomic implications for the health care system. In
1997, the annual direct cost of treating newly diag-
nosed melanoma cases was about $563 million.5
About 90% of the total cost was directed toward the
treatment of patients with advanced disease.5 Public
education campaigns may increase awareness and
knowledge of the disease, which may lead to behavior
changes that have an impact on both primary preven-
tion and early detection.6 Similarly, professional edu-
cation of physicians and integration of skin examina-
tions into physical examinations may lead to early
detection.6 Early detection of melanoma may have a
relatively immediate impact on decreasing mortality
rates.7 In the U.S. population, deficiencies in knowl-
edge and practices promoting early detection have
shown the need for public education.8 Miller et al.8
surveyed a nationally representative sample of 1001
persons in the United States. They found that nearly
42% were unaware of the term melanoma and only
26% of those who were aware could identify its spe-
cific signs. Awareness and knowledge were more com-
mon among women, Caucasians, adults over 25 years
of age, and among those with higher levels of educa-
tion and income. They also discovered that 54% of
TABLE 4
Lesion Signs and Symptomsa
Lesion sign/symptom No. of lesions (n  1630) (%) Mean depth (mm)
Color change 703 (43) 1.15  0.12
Size change 710 (44) 1.33  0.14
Shape/elevation change 659 (40) 1.47  0.15
Ulceration 149 (9) 2.69  0.37
Bleeding 208 (13) 2.63  0.34
Tenderness 151 (9) 2.44  0.42
Itching 267 (16) 1.70  0.25




All (n  1630 lesions) Males (n  849 lesions) Females (n  781 lesions)
No. (%) Mean depth (mm) No. (%) Mean depth (mm) No. (%) Mean depth (mm)
Patient 1,037 (64) 1.17  0.11 445 (52) 1.42  0.18 592 (76) 0.98  0.13
Physician 231 (14) 0.40  0.08 159 (19) 0.42  0.10 72 (9) 0.35  0.14
Spouse 181 (11) 1.00  0.16 161 (19) 1.04  0.17 20 (3) 0.72  0.36
Otherb 181 (11) 84 (10) 97 (12)
a  95% confidence interval.
b Other includes friend, sibling, son/daughter, parent, nurse, unknown/not available.
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respondents never examined their skin because of low
awareness, little knowledge, or denial of risk. These
authors concluded that future educational programs
should focus on increasing concern and knowledge of
melanoma.8 Oliveria et al.9 showed that awareness of
skin changes was correlated with a thinner melanoma
and more immediate medical attention and that
knowledge of the signs and symptoms also contrib-
uted to less delay in diagnosis. Campaigns to increase
awareness and promote skin self-examinations have
been developed by the American Academy of Derma-
tology. To gain further insight into targeting public
and professional educational campaigns for early de-
tection, this study evaluated the relationship between
tumor thickness and patient demographics, detection
patterns, lesion signs and symptoms, and personal
and family history of melanoma. This is the largest
prospective study to evaluate the relationship between
Breslow depth and detection patterns, lesion charac-
teristics, and patient characteristics.
Patient Demographics
Educating and screening patients at high risk for mel-
anoma (skin types I, II, or III, atypical nevi, many
clinically benign nevi, significant sun exposure, or per-
sonal or family history of melanoma) about skin self-
examination and physician examinations will con-
tinue to promote the early detection of thin
melanoma.10 –12 However, strategies aimed at educat-
ing only this population will fail to make an impact on
decreasing the incidence of deeper melanomas that
were seen in low-risk groups in this study. Although
high-risk groups are more likely, by definition, to have
melanoma, our data indicate that this group already
tends to present with early disease. Based on our data,
we suggest that education to promote early detection
should specifically address low-risk groups because
thicker lesions are found more frequently among
these individuals.
In our study, patients with skin types I, II, or III
had thinner lesions than patients with skin types IV or
V. Although not statistically significant, this is consis-
tent with our clinical impression and the published
literature.13 This may suggest less awareness and
knowledge of melanoma in non-Caucasians. Miller et
al.8 found lower measures of melanoma knowledge
and attitudes among non-Caucasians compared with
Caucasians.
Our study showed that patients with atypical
nevi had thinner melanomas than patients without
atypical nevi. This earlier detection may be a result
of increased screening and surveillance of these pa-
tients because of awareness of a higher risk of mel-
anoma.10 In our study, patients with greater than 20
clinically benign nevi had significantly thinner mel-
anomas than patients with 20 or less clinically be-
nign nevi.
The patients in this study who reported a history
of sunburn had thinner lesions than patients who
recalled no history of sunburn, although this was
not statistically significant. An awareness of sun-
burn as a risk factor for melanoma14 and other skin
carcinomas by either patient or physician may lead
to increased surveillance by both patients and phy-
sicians and to detection of earlier disease in patients
who give a history of sunburn independent of actual
exposure.
TABLE 5
Personal and Family History of Melanomaa
All Males Females
No. (%) Mean depth (mm) No. (%) Mean depth (mm) No. (%) Mean depth (mm)
Personal historyb
Primary n  1630 lesions n  849 lesions n  781 lesions
1st 1530 (94) 1.06  0.08 784 (92) 1.20  0.12 746 (96) 0.91  0.11
2nd 79 (5) 0.42  0.16 54 (6) 0.46  0.22 25 (3) 0.34  0.16
3rd 18 (1) 0.28  0.17 10 (1) 0.31  0.21 8 (1) 0.24  0.35
4th 2 0.44 1 0.46 1 0.41
5th 1 3.83 0 1 3.83
Family historyc n  1515 patients n  774 patients n  741 patients
Yes 231 (15) 0.83  0.20 103 (13) 0.82  0.19 128 (17) 0.83  0.33
No 1257 (83) 1.02  0.08 654 (84) 1.14  0.12 603 (81) 0.89  0.11
a  95% confidence interval.
b Categories may not total 100% due to rounding errors.
c Categories may not total 100% due to missing or unknown responses.
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Detection Patterns
Educational campaigns for the public are essential
because the majority of lesions are not detected by
health care professionals. Our study and studies by
Koh et al.,15 Brady et al.,16 and Epstein et al.17 showed
that the majority of melanomas were detected by pa-
tients. Similar percentages were noted among the four
studies, i.e., 64%, 53%, 57%, and 55%, respectively.
Our study and others also showed that females were
more likely than males to detect their own lesions15–17
and this study showed that the lesions detected were
thinner. This may be accounted for by the findings of
other investigators that women are more aware of the
disease, more likely to participate in screening pro-
grams and perform skin self-examinations, and more
likely to seek early medical evaluation of lesions.8,18
Therefore, educational programs should specifically
include increasing melanoma awareness among
males.
Physicians who detect melanomas tend to identify
early lesions. Our study showed that physician-de-
tected lesions were significantly thinner than either
self-detected or spouse-detected lesions. Brady et al.16
and Epstein et al.17 also concluded that thinner mel-
anomas were more likely to be physician detected.
However, physician detection was less common than
patient detection among the three studies. One pos-
sible explanation is that few physicians examine the
skin of their patients. Geller et al.19 reported that 87%
of 216 melanoma patients had regular physicians and
63% saw their physicians in the year before diagnosis.
Many patients did not have skin examinations by their
physicians nor did they perform skin self-examina-
tions. Few physicians have little or no training in the
identification of melanomas, particularly the early de-
tection of these lesions. Stephenson et al.20 found that
greater than 50% of family physicians lacked confi-
dence in recognizing melanoma. Cassileth et al.21
showed that only 38% of nondermatologist physicians
correctly identified at least four of six melanomas
compared with 92% of dermatologists. Perhaps, more
comprehensive training of physicians, particularly pri-
mary care physicians, at identifying early melanomas
and encouraging them to perform skin examinations
as part of health maintenance may increase the detec-
tion of early disease.
Lesion Signs and Symptoms
Both the public and physicians should be educated as
to the early signs of melanoma such as a change in
color, size, or shape, to maximize the detection of
early disease. Our study showed that thinner lesions
were associated with a change in color, size, shape/
elevation, or itching, whereas ulceration, bleeding, or
tenderness were signs of significantly thicker lesions.
This is compatible with the findings of other investi-
gators. Wick et al.22 and Sober et al.23 showed that a
change in color and an increase in size were most
useful in the detection of early lesions, whereas eleva-
tion, bleeding, or ulceration were associated more fre-
quently with thicker melanomas. Based on the results
of all these studies, it is reasonable to conclude that
educational campaigns promoting the early signs and
symptoms of melanoma, including a change in color,
size, or shape, or pruritus, may increase the detection
of early disease.
Personal and Family History of Melanoma
A previous personal history of melanoma is a strong
risk factor for the development of subsequent mela-
nomas,24 frequently leading to regular physician and
skin self-examinations. Several investigators studying
patients with multiple primary melanomas have re-
ported a decrease in thickness from first to subse-
quent primaries.11,12 In our study, second and third
primary melanomas were detected earlier than first
primary melanomas. First primaries in females were
significantly thinner than in males. However, Breslow
depths of second and third primaries were compara-
ble in both males and females, suggesting that a per-
sonal history of melanoma impacts positively on ed-
ucation of and surveillance in males.
Similarly, patients with a family history of mela-
noma may already have an increased awareness of
melanoma. Brady et al.16 found that patients who
reported a family history of melanoma were more
likely to present with a thin lesion. Our study also
concluded that patients with a family history of mel-
anoma had earlier detection of disease than patients
without a family history of melanoma, although this
was not statistically significant. However, there was a
significant difference in the thickness of lesions in
males with and without a family history of melanoma.
This observation suggests that not only a personal but
also a family history of melanoma impacts positively
on education of and surveillance in males.
In summary, patient characteristics associated
with early detection included female gender, at least
one atypical nevus, greater than 20 clinically benign
nevi, and/or a personal history of melanoma. Skin
types I, II, and III, history of sunburn, and/or a family
history of melanoma were also associated with thinner
lesions, but not at a statistically significant level. Le-
sion characteristics associated with earlier detection
included a change in color, size, shape/elevation,
and/or itching. Physician-detected melanomas were
significantly thinner but represented a relatively small
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percentage of melanomas. This study suggests that
educational campaigns that increase melanoma
awareness and screening in males may be beneficial.
Although screening only high-risk groups may be eco-
nomically advantageous, our data suggest that educa-
tional campaigns to increase melanoma awareness
should be directed at both high and low-risk groups.
Physicians and other health care providers should be
aware of the importance and potential benefit of total
body skin examinations for both high and low-risk
patients.
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